Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinesin family member 11 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0088 | 0.2556 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0088 | 0.2556 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0088 | 0.2556 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0034 | 0 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0088 | 0.2556 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0088 | 0.2556 | 0.1754 |
Brugia malayi | FAD binding domain containing protein | 0.0055 | 0.0973 | 0.3805 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0044 | 0.0471 | 0.5 |
Treponema pallidum | flavodoxin | 0.0034 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0034 | 0 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0088 | 0.2556 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0055 | 0.0973 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0088 | 0.2556 | 0.1754 |
Trypanosoma cruzi | p450 reductase, putative | 0.0088 | 0.2556 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0044 | 0.0471 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0088 | 0.2556 | 0.1754 |
Echinococcus multilocularis | kinesin family 1 | 0.0247 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0088 | 0.2556 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0088 | 0.2556 | 0.2599 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.2556 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0055 | 0.0973 | 0.3805 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0078 | 0.2086 | 0.8159 |
Brugia malayi | flavodoxin family protein | 0.0088 | 0.2556 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0088 | 0.2556 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0045 | 0.0502 | 0.0039 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0088 | 0.2556 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0034 | 0 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0088 | 0.2556 | 0.1754 |
Giardia lamblia | Hypothetical protein | 0.0078 | 0.2086 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0215 | 0.8495 | 1 |
Leishmania major | cytochrome P450 reductase, putative | 0.0078 | 0.2086 | 0.8159 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0088 | 0.2556 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0055 | 0.0973 | 0.0626 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0078 | 0.2086 | 0.8159 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0088 | 0.2556 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0088 | 0.2556 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0088 | 0.2556 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0034 | 0 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0088 | 0.2556 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0078 | 0.2086 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0034 | 0 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0088 | 0.2556 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0088 | 0.2556 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.